398 related articles for article (PubMed ID: 9111297)
21. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
[TBL] [Abstract][Full Text] [Related]
22. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
23. Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.
Messer WS; Rajeswaran WG; Cao Y; Zhang HJ; el-Assadi AA; Dockery C; Liske J; O'Brien J; Williams FE; Huang XP; Wroblewski ME; Nagy PI; Peseckis SM
Pharm Acta Helv; 2000 Mar; 74(2-3):135-40. PubMed ID: 10812950
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Sadashiva CT; Chandra JN; Kavitha CV; Thimmegowda A; Subhash MN; Rangappa KS
Eur J Med Chem; 2009 Dec; 44(12):4848-54. PubMed ID: 19717214
[TBL] [Abstract][Full Text] [Related]
25. 1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonists.
Ward JS; Merritt L; Calligaro DO; Bymaster FP; Shannon HE; Mitch CH; Whitesitt C; Brunsting D; Sheardown MJ; Olesen PH; Swedberg MD; Jeppesen L; Sauerberg P
J Med Chem; 1998 Jan; 41(3):379-92. PubMed ID: 9464368
[TBL] [Abstract][Full Text] [Related]
26. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
[TBL] [Abstract][Full Text] [Related]
27. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
[TBL] [Abstract][Full Text] [Related]
28. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
[TBL] [Abstract][Full Text] [Related]
29. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
Miyoshi S; Tu AT
Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
[TBL] [Abstract][Full Text] [Related]
30. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
[TBL] [Abstract][Full Text] [Related]
31. Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Asha D; Chandra JN; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 Aug; 16(15):7095-101. PubMed ID: 18640043
[TBL] [Abstract][Full Text] [Related]
32. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
Wall SJ; Yasuda RP; Li M; Wolfe BB
Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Dunbar PG; Durant GJ; Fang Z; Abuh YF; el-Assadi AA; Ngur DO; Periyasamy S; Hoss WP; Messer WS
J Med Chem; 1993 Apr; 36(7):842-7. PubMed ID: 8464038
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
Mei L; Lai J; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
[TBL] [Abstract][Full Text] [Related]
35. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
Balduini W; Murphy SD; Costa LG
J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
[TBL] [Abstract][Full Text] [Related]
36. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists.
Rajeswaran WG; Cao Y; Huang XP; Wroblewski ME; Colclough T; Lee S; Liu F; Nagy PI; Ellis J; Levine BA; Nocka KH; Messer WS
J Med Chem; 2001 Dec; 44(26):4563-76. PubMed ID: 11741475
[TBL] [Abstract][Full Text] [Related]
39. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
[TBL] [Abstract][Full Text] [Related]
40. 2-(Substituted)amino-2,8-diazaspiro[4,5]decan-1,3-diones as potential muscarinic agonists: synthesis, modeling and binding studies.
Barlocco D; Fanelli F; Cignarella G; Villa S; Cattabeni F; Balduini W; Cimino M; De Benedetti PG
Drug Des Discov; 1996 Oct; 14(2):129-43. PubMed ID: 9010619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
